title: Hypoxia-activated prodrugs forge ahead in cancer.
authors.forename: Jim
authors.initials: J
authors.lastname: Kling
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001709:Biotechnology / Q000379:methods; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000639:trends; D006801:Humans; D000860:Hypoxia; D008495:Medical Oncology / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy*; D010641:Phenotype; D011355:Prodrugs / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D011355:Prodrugs